DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Small Molecule Drugs cited in Mallinckrodt IP v. B. Braun Medical Inc.
|Date Filed||Document No.||Description||Snippet||Link To Document|
|2017-04-03||1||Complaint||6,992,218 (“the ’218 patent”) (collectively, the “patents-in-suit”). 2. Plaintiff Mallinckrodt… U.S. Patent No. 9,399,012 (“the ’012 patent”) and is the exclusive sub-licensee of U.S. Patent No. 6,992,218… action for infringement of the patents-in-suit pursuant to the Patent Laws of the United States, 35 …involves patents that are or were at issue in other actions before this Court. The ’218 patent was at … THE PATENTS-IN-SUIT 14. The ’218 patent, titled “Method for Obtaining||External link to document|
|2018-05-17||158||Memorandum and Order||for infringement of U.S . Patent Nos. 6,992,218 (the '" 218 patent") and 9,399,012 (the…claimed in a patent or the use of which is claimed in a patent before the expiration of such patent." … of the ' 012 patent and U.S . Patent No. 9,610,265 (the "' 265 patent"), is DENIED…discovery from SCR Pharmatop or the inventors on the patents-in-suit, the Court disagrees. 2. … standing, including unredacted versions of the Patent Assignment Agreement and the Asset Purchase Agreement||External link to document|
|2018-06-05||167||Opinion - Memorandum Opinion||to a Paragraph IV certification to U.S . Patent No. 6,992,218 from Defendant B. Braun Medical Inc. (&… 012 patent and U.S. Patent No. 9,610,265 (collectively with the ' 012 and ' 218 patents, the …alleging infringement of the ' 218 patent and U.S . Patent No. 9,399,012. On May 31, 2017, in response…the "asserted patents"). The ' 218 patent is directed to the manufacture of aqueous formulations…quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which the||External link to document|
|>Date Filed||>Document No.||>Description||>Snippet||>Link To Document|